AU570529B2 - 5-heteroarylimidazol-2-ones - Google Patents

5-heteroarylimidazol-2-ones

Info

Publication number
AU570529B2
AU570529B2 AU36783/84A AU3678384A AU570529B2 AU 570529 B2 AU570529 B2 AU 570529B2 AU 36783/84 A AU36783/84 A AU 36783/84A AU 3678384 A AU3678384 A AU 3678384A AU 570529 B2 AU570529 B2 AU 570529B2
Authority
AU
Australia
Prior art keywords
compound
loweralkyl
heteroaryl
compounds
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU36783/84A
Other languages
English (en)
Other versions
AU3678384A (en
Inventor
David M. Stout
Diane M. Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
American Hospital Supply Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hospital Supply Corp filed Critical American Hospital Supply Corp
Publication of AU3678384A publication Critical patent/AU3678384A/en
Application granted granted Critical
Publication of AU570529B2 publication Critical patent/AU570529B2/en
Assigned to E.I. DU PONT DE NEMOURS AND COMPANY reassignment E.I. DU PONT DE NEMOURS AND COMPANY Alteration of Name(s) in Register under S187 Assignors: AMERICAN HOSPITAL SUPPLY CORP.
Assigned to DU PONT MERCK PHARMACEUTICAL COMPANY, THE reassignment DU PONT MERCK PHARMACEUTICAL COMPANY, THE Alteration of Name(s) in Register under S187 Assignors: E.I. DU PONT DE NEMOURS AND COMPANY
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Treating Waste Gases (AREA)
AU36783/84A 1983-11-23 1984-11-13 5-heteroarylimidazol-2-ones Ceased AU570529B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US554498 1983-11-23
US06/554,498 US4532250A (en) 1983-11-23 1983-11-23 5-Heteroarylimidazol-2-ones having cardiotonic activity

Publications (2)

Publication Number Publication Date
AU3678384A AU3678384A (en) 1985-06-13
AU570529B2 true AU570529B2 (en) 1988-03-17

Family

ID=24213587

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36783/84A Ceased AU570529B2 (en) 1983-11-23 1984-11-13 5-heteroarylimidazol-2-ones

Country Status (8)

Country Link
US (1) US4532250A (enExample)
EP (1) EP0162102B1 (enExample)
JP (1) JPS61500494A (enExample)
AU (1) AU570529B2 (enExample)
CA (1) CA1258072A (enExample)
DE (1) DE3480475D1 (enExample)
IT (1) IT1178243B (enExample)
WO (1) WO1985002402A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649146A (en) * 1983-01-31 1987-03-10 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives and pharmaceutical composition comprising the same
NZ212209A (en) * 1984-05-29 1988-08-30 Pfizer Quinolone derivatives and pharmaceutical compositions
US4670450A (en) * 1985-11-13 1987-06-02 Merrell Dow Pharmaceuticals Inc. Cardiotonic thiazolones
US4728661A (en) * 1985-11-13 1988-03-01 Merrell Dow Pharmaceuticals Inc. Cardiotonic phenyl oxazolones
US4698353A (en) * 1985-11-13 1987-10-06 Merrell Dow Pharmaceuticals Inc. Cardiotonic heterocyclic oxazolones
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
US4999365A (en) * 1987-03-20 1991-03-12 Merrell Dow Pharmaceuticals Inc. Method of reducing reperfusion injury with imidazol-2-thiones
US4743607A (en) * 1987-05-29 1988-05-10 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic imidazolones
US4803210A (en) * 1987-05-29 1989-02-07 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic oxazolones
GB8827820D0 (en) * 1988-11-29 1988-12-29 Janssen Pharmaceutica Nv (1h-azol-1-ylmethyl)substituted quinoline derivatives
US5593991A (en) * 1993-07-16 1997-01-14 Adams; Jerry L. Imidazole compounds, use and process of making
AR017200A1 (es) 1997-12-23 2001-08-22 Astrazeneca Ab Compuestos inhibidores de la proteina cinasa c, sales farmaceuticamente aceptables de los mismos, formulaciones farmaceuitcas que los comprenden, usode las mismas y proceso para la sintesis de dichos compuestos
SE9800835D0 (sv) 1998-03-13 1998-03-13 Astra Ab New Compounds
US6492406B1 (en) 1999-05-21 2002-12-10 Astrazeneca Ab Pharmaceutically active compounds
US6346625B1 (en) 1999-06-23 2002-02-12 Astrazeneca Ab Protein kinase inhibitors
AU2004201666C1 (en) * 2001-10-22 2006-10-12 Tanabe Seiyaku Co., Ltd. 4-Imidazolin-2-one compounds
US7473695B2 (en) * 2001-10-22 2009-01-06 Mitsubishi Tanabe Pharma Corporation 4-imidazolin-2-one compounds
IL160874A0 (en) * 2001-10-22 2004-08-31 Tanabe Seiyaku Co 4-imidazolin-2-one derivatives
ATE504583T1 (de) * 2003-04-21 2011-04-15 Mitsubishi Tanabe Pharma Corp 4-imidazolin-2-onverbindungen

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU550035B2 (en) * 1981-02-19 1986-02-27 Yamanouchi Pharmaceutical Co., Ltd. 3,5-di-tert-butyl-4-hydroxyphenyl substituted heterocyclic compound

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2585388A (en) * 1948-11-17 1952-02-12 Lilly Co Eli Preparation of 2-mercaptoimidazoles
US3303199A (en) * 1963-07-15 1967-02-07 Geigy Chem Corp Certain imidazolone derivatives and process for making same
GB1155580A (en) * 1965-10-21 1969-06-18 Geigy Ag J R New Imidazole Derivatives their Production and Use
US3641049A (en) * 1968-10-29 1972-02-08 Jan Olof Sandstrom Imidazoline-2-thiones
US3538104A (en) * 1969-02-28 1970-11-03 Geigy Chem Corp Pyridyl-2-imidazolones
JPS5343958B2 (enExample) * 1972-07-29 1978-11-24
US4053480A (en) * 1976-04-26 1977-10-11 Velsicol Chemical Corporation 1-thiadiazolyl-5-phenoxy- and phenylthioalkanoyloxy imidazolidinones
US4405635A (en) * 1979-06-18 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Aroylimidazol-2-ones and their use as pharmaceuticals
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
NZ202351A (en) * 1981-11-04 1986-02-21 Merrell Dow Pharma Imidazole carboxamines
PH19153A (en) * 1981-11-04 1986-01-15 Merrell Dow Pharma Treatment of cardiac failure using imidazolecarboxylic acid derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU550035B2 (en) * 1981-02-19 1986-02-27 Yamanouchi Pharmaceutical Co., Ltd. 3,5-di-tert-butyl-4-hydroxyphenyl substituted heterocyclic compound

Also Published As

Publication number Publication date
WO1985002402A1 (en) 1985-06-06
IT8449177A0 (it) 1984-11-16
IT1178243B (it) 1987-09-09
IT8449177A1 (it) 1986-05-16
EP0162102B1 (en) 1989-11-15
CA1258072A (en) 1989-08-01
AU3678384A (en) 1985-06-13
EP0162102A4 (en) 1986-03-18
JPS61500494A (ja) 1986-03-20
JPH0572390B2 (enExample) 1993-10-12
US4532250A (en) 1985-07-30
EP0162102A1 (en) 1985-11-27
DE3480475D1 (de) 1989-12-21

Similar Documents

Publication Publication Date Title
US4532250A (en) 5-Heteroarylimidazol-2-ones having cardiotonic activity
KR890002290B1 (ko) 피페라진 유도체 및 그의 제조방법
KR0164842B1 (ko) 신규 벤즈옥사진, 벤조티아진 유도체 및 그 제조방법
JPS63502031A (ja) ヒドロキシおよびアミノチオゾリル−ベンゾジアジノン化合物、これを含む強心性組成物、およびその使用
AU568087B2 (en) Heteroaryl substituted aminomethyl benzene derivatives
EP0539153B1 (en) Acridine derivative as therapeutic agent
JPH0466571A (ja) 脳及び心機能障害改善剤
US4921856A (en) Dihydropyridazinone derivatives, a process for their preparation and pharmaceutical preparations containing these compounds
JP3083544B2 (ja) 心疾患を予防または治療する薬剤
SU1087519A1 (ru) Соли производных 1,2,4-оксадиазолин-5-она про вл ющие свойства регул торов де тельности сердечно-сосудистой системы
NO165635B (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive kinolinderivater.
GB2095240A (en) Dihydropyrimidine derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
JPH01500596A (ja) ピリドン‐ピリジル‐イミダゾリルおよびトリアゾリル化合物並びにそれらの強心薬としての使用
OA12256A (en) Sodium-hydrogen exchanger type 1 inhibitor (NHE-1).
PL92078B1 (enExample)
US4657919A (en) Pyridone esters as inotropic agents
US4555517A (en) Pyridone esters as inotropic agents
GB2066251A (en) 3-acylamino-s-(pyridinyl)-2(1h)-pyridinones
US4486431A (en) Cardiotonic use of 4,5-dihydro-6-(4-pyridinyl)-3(2H)-pyridazinones
IE53586B1 (en) Triazole gastric anti-secretory agents
EP0257918A1 (en) Quinolone cardiac stimulants
US3426034A (en) Omega-phenyl-omega-pyridyl alkylamine derivatives
EP0405784A1 (en) Novel benzisoquinoline derivatives
CA2223388A1 (en) Diheterocyclic acrylonitriles as smooth muscle cell proliferation inhibitors
US4507304A (en) Use of 6-amino-5-pyrimidinecarbonitrile derivatives as cardiotonic agents